Breaking News Instant updates and real-time market news.

REGI

Renewable Energy

$88.05 /

+3.12 (+3.67%)

08:47
01/08/21
01/08
08:47
01/08/21
08:47

Renewable Energy price target raised to $100 from $75 at BWS Financial

BWS Financial analyst Hamed Khorsand raised the firm's price target on Renewable Energy to $100 from $75 to reflect his higher adjusted EBITDA estimate for 2021 given how he sees higher renewable identification numbers, or "RIN," prices contributing to an increase in earnings. Khorsand, who keeps a Buy rating on the shares, argues that the risk to input costs rising has "been put on hold" since RIN and low carbon fuel standard credit prices have increased in value faster than feedstock prices.

  • 15

    Mar

REGI Renewable Energy
$88.05 /

+3.12 (+3.67%)

10/21/20 Wolfe Research
Renewable Energy initiated with an Outperform at Wolfe Research
10/12/20 Credit Suisse
Renewable Energy price target raised to $74 from $60 at Credit Suisse
10/06/20 Roth Capital
Renewable Energy price target raised to $70 from $50 at Roth Capital
09/28/20 BWS Financial
Renewable Energy price target raised to $75 from $58 at BWS Financial

TODAY'S FREE FLY STORIES

Initiation
Chesswood Group initiated with an Outperform at Raymond James » 07:25
06/24/21
06/24
07:25
06/24/21
07:25
CHWWF

Chesswood Group

$11.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
Needham starts 'preeminent franchise' Analog Devices with Buy rating » 07:25
06/24/21
06/24
07:25
06/24/21
07:25
ADI

Analog Devices

$163.60 /

-0.13 (-0.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

06:30 Today Needham
Analog Devices initiated with a Buy at Needham
05/20/21 Truist
Analog Devices price target lowered to $179 from $183 at Truist
05/20/21 Deutsche Bank
Analog Devices price target raised to $165 from $160 at Deutsche Bank
05/20/21 Bernstein
Analog Devices upgraded to Outperform from Market Perform at Bernstein
ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

Hot Stocks
Corvus Gold announces additional results from Mother Lode program » 07:25
06/24/21
06/24
07:25
06/24/21
07:25
KOR

Corvus Gold

$2.68 /

+0.02 (+0.75%)

Corvus Gold announces it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KOR Corvus Gold
$2.68 /

+0.02 (+0.75%)

KOR Corvus Gold
$2.68 /

+0.02 (+0.75%)

04/15/21 BMO Capital
Corvus Gold initiated with an Outperform at BMO Capital
Recommendations
Winnebago price target lowered to $86 from $94 at Wedbush » 07:24
06/24/21
06/24
07:24
06/24/21
07:24
WGO

Winnebago

$65.98 /

-0.825 (-1.23%)

Wedbush analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WGO Winnebago
$65.98 /

-0.825 (-1.23%)

WGO Winnebago
$65.98 /

-0.825 (-1.23%)

06:35 Today Baird
Winnebago elevated to bullish Fresh Pick at Baird
06/17/21 Northcoast
Northcoast downgrades three RV makers to Neutral following industry checks
06/17/21 Northcoast
Winnebago downgraded to Neutral from Buy at Northcoast
05/03/21 Citi
Winnebago price target raised to $93 from $73 at Citi
WGO Winnebago
$65.98 /

-0.825 (-1.23%)

WGO Winnebago
$65.98 /

-0.825 (-1.23%)

Hot Stocks
4D Molecular announces expected upcoming milestones » 07:23
06/24/21
06/24
07:23
06/24/21
07:23
FDMT

4D Molecular

$24.81 /

+0.91 (+3.81%)

4D-125: Initial biologic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
  • 11
    Dec
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

Hot Stocks
4D Molecular announces initial safety data for 4D-110, 4D-125 » 07:23
06/24/21
06/24
07:23
06/24/21
07:23
FDMT

4D Molecular

$24.81 /

+0.91 (+3.81%)

4D Molecular Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
  • 11
    Dec
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

Hot Stocks
Eli Lilly jumps on expedited plans for Alzheimer's drug, Biogen falls » 07:22
06/24/21
06/24
07:22
06/24/21
07:22
LLY

Eli Lilly

$217.08 /

-4.51 (-2.04%)

, BIIB

Biogen

$371.82 /

-2.77 (-0.74%)

Eli Lilly (LLY) announced…

Eli Lilly (LLY) announced that the Food and Drug Administration granted Breakthrough Therapy designation for donanemab, its investigational antibody therapy for Alzheimer's disease. Lilly intends to submit a biologics license application for donanemab under the accelerated approval pathway later this year based on data from TRAILBLAZER-ALZ. The safety, tolerability and efficacy of donanemab are also being evaluated in the ongoing Phase 3 study TRAILBLAZER-ALZ 2, the company said in a statement. The Phase 2 trial, TRAILBLAZER-ALZ, studied the efficacy and safety of donanemab in patients with early, symptomatic Alzheimer's. Shares of Eli Lilly are up 9%, or $18.50, to $235.60 following the news. Shares of Biogen (BIIB), who recently received FDA approval for its Alzheimer's treatment, are down 6% to $350.02 in premarket trading.

ShowHide Related Items >><<
LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

06/15/21 JPMorgan
Eli Lilly price target raised to $260 from $240 at JPMorgan
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
BIIB Biogen
$371.82 /

-2.77 (-0.74%)

06/18/21
Fly Intel: Top five analyst upgrades
06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
06/18/21 BofA
BofA upgrades Prothena to Neutral on PRX012 potential following Aduhelm approval
06/18/21 Piper Sandler
Biogen upgraded to Overweight from Neutral at Piper Sandler
LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

Hot Stocks
Aileron Therapeutics set to join Russell Microcap Index » 07:21
06/24/21
06/24
07:21
06/24/21
07:21
ALRN

Aileron Therapeutics

$1.28 /

+0.04 (+3.23%)

Aileron Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALRN Aileron Therapeutics
$1.28 /

+0.04 (+3.23%)

ALRN Aileron Therapeutics
$1.28 /

+0.04 (+3.23%)

Initiation
Truist starts Taysha Gene Therapies at Buy on potential de-risking events » 07:21
06/24/21
06/24
07:21
06/24/21
07:21
TSHA

Taysha Gene Therapies

$25.25 /

+0.07 (+0.28%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$25.25 /

+0.07 (+0.28%)

TSHA Taysha Gene Therapies
$25.25 /

+0.07 (+0.28%)

06:12 Today Truist
Taysha Gene Therapies initiated with a Buy at Truist
06/14/21 BTIG
Taysha Gene Therapies initiated with a Buy at BTIG
06/09/21 Wedbush
Taysha Gene Therapies initiated with an Outperform at Wedbush
06/08/21 JMP Securities
Taysha Gene Therapies initiated with an Outperform at JMP Securities
TSHA Taysha Gene Therapies
$25.25 /

+0.07 (+0.28%)

  • 24
    Sep
Hot Stocks
Vectivbio receives FDA orphan drug designation for apraglutide » 07:21
06/24/21
06/24
07:21
06/24/21
07:21
VECT

Vectivbio

$12.64 /

-1.26 (-9.06%)

VectivBio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VECT Vectivbio
$12.64 /

-1.26 (-9.06%)

VECT Vectivbio
$12.64 /

-1.26 (-9.06%)

05/04/21 SVB Leerink
SVB Leerink bullish on Vectivbio, initiates with an Outperform
05/04/21 SVB Leerink
Vectivbio initiated with an Outperform at SVB Leerink
05/04/21 BofA
Vectivbio initiated with a Buy at BofA
05/04/21 Credit Suisse
Vectivbio initiated with an Outperform at Credit Suisse
  • 09
    Apr
VECT Vectivbio
$12.64 /

-1.26 (-9.06%)

Hot Stocks
4D Molecular anounces rare disease ophthalmology product candidate update » 07:20
06/24/21
06/24
07:20
06/24/21
07:20
FDMT

4D Molecular

$24.81 /

+0.91 (+3.81%)

"We believe the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
  • 11
    Dec
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

Hot Stocks
Werewolf Therapeutics set to join Russell 2000 Index » 07:19
06/24/21
06/24
07:19
06/24/21
07:19
HOWL

Werewolf Therapeutics

$15.09 /

+0.39 (+2.65%)

Werewolf Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HOWL Werewolf Therapeutics
$15.09 /

+0.39 (+2.65%)

HOWL Werewolf Therapeutics
$15.09 /

+0.39 (+2.65%)

05/25/21
Fly Intel: Top five analyst initiations
05/25/21 SVB Leerink
SVB Leerink bullish on Werewolf Therapeutics, initiates with an Outperform
05/25/21 SVB Leerink
Werewolf Therapeutics initiated with an Outperform at SVB Leerink
05/25/21 Evercore ISI
Werewolf Therapeutics initiated with an Outperform at Evercore ISI
HOWL Werewolf Therapeutics
$15.09 /

+0.39 (+2.65%)

  • 30
    Apr
HOWL Werewolf Therapeutics
$15.09 /

+0.39 (+2.65%)

Hot Stocks
Enthusiast Gaming closes acquisition of Tabwire for $11M in cash, stock » 07:18
06/24/21
06/24
07:18
06/24/21
07:18
EGLX

Enthusiast Gaming

$5.75 /

+0.405 (+7.58%)

Enthusiast Gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGLX Enthusiast Gaming
$5.75 /

+0.405 (+7.58%)

EGLX Enthusiast Gaming
$5.75 /

+0.405 (+7.58%)

06/23/21 H.C. Wainwright
Enthusiast Gaming initiated with a Buy at H.C. Wainwright
  • 11
    Jun
EGLX Enthusiast Gaming
$5.75 /

+0.405 (+7.58%)

Initiation
Vaxart initiated with a Buy at Jefferies » 07:18
06/24/21
06/24
07:18
06/24/21
07:18
VXRT

Vaxart

$7.84 /

-0.05 (-0.63%)

Jefferies analyst Kelechi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VXRT Vaxart
$7.84 /

-0.05 (-0.63%)

VXRT Vaxart
$7.84 /

-0.05 (-0.63%)

06/11/21
Fly Intel: Top five analyst initiations
06/11/21 Piper Sandler
Vaxart initiated with an Overweight at Piper Sandler
03/04/21 B. Riley Securities
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley Securities
Vaxart price target lowered to $16 from $22 at B. Riley Securities
VXRT Vaxart
$7.84 /

-0.05 (-0.63%)

VXRT Vaxart
$7.84 /

-0.05 (-0.63%)

VXRT Vaxart
$7.84 /

-0.05 (-0.63%)

VXRT Vaxart
$7.84 /

-0.05 (-0.63%)

Hot Stocks
4D Molecular announces termination of Roche collaboration, license agreement » 07:18
06/24/21
06/24
07:18
06/24/21
07:18
FDMT

4D Molecular

$24.81 /

+0.91 (+3.81%)

, RHHBY

Roche

$46.13 /

-0.67 (-1.43%)

Roche (RHHBY) requested…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

RHHBY Roche
$46.13 /

-0.67 (-1.43%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
RHHBY Roche
$46.13 /

-0.67 (-1.43%)

06/14/21 Berenberg
Roche price target raised to CHF 340 from CHF 320 at Berenberg
06/10/21 Morgan Stanley
Roche price target raised to CHF 370 from CHF 345 at Morgan Stanley
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Societe Generale
Roche downgraded to Hold from Buy at Societe Generale
RHHBY Roche
$46.13 /

-0.67 (-1.43%)

  • 11
    Dec
RHHBY Roche
$46.13 /

-0.67 (-1.43%)

RHHBY Roche
$46.13 /

-0.67 (-1.43%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

Hot Stocks
Corvus Gold announces additional results from Mother Lode program » 07:17
06/24/21
06/24
07:17
06/24/21
07:17
KOR

Corvus Gold

$2.68 /

+0.02 (+0.75%)

Corvus Gold announces it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KOR Corvus Gold
$2.68 /

+0.02 (+0.75%)

KOR Corvus Gold
$2.68 /

+0.02 (+0.75%)

04/15/21 BMO Capital
Corvus Gold initiated with an Outperform at BMO Capital
Hot Stocks
Bio-Techne and Catamaran Bio expand collaboration for CAR-NK cell therapies » 07:16
06/24/21
06/24
07:16
06/24/21
07:16
TECH

Bio-Techne

$444.01 /

+3.1 (+0.70%)

Bio-Techne and Catamaran…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TECH Bio-Techne
$444.01 /

+3.1 (+0.70%)

TECH Bio-Techne
$444.01 /

+3.1 (+0.70%)

06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
05/07/21 Baird
Bio-Techne price target raised to $430 from $410 at Baird
03/08/21 Stephens
Bio-Techne upgraded to Overweight from Equal Weight at Stephens
02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
TECH Bio-Techne
$444.01 /

+3.1 (+0.70%)

Hot Stocks
FDA accepts Alnylam NDA for vutrisiran, an investigational RNAi therapeutic » 07:15
06/24/21
06/24
07:15
06/24/21
07:15
ALNY

Alnylam

$174.69 /

+1.64 (+0.95%)

Alnylam Pharmaceuticals …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALNY Alnylam
$174.69 /

+1.64 (+0.95%)

ALNY Alnylam
$174.69 /

+1.64 (+0.95%)

06/11/21 BMO Capital
Alnylam coverage transferred at BMO Capital
02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
ALNY Alnylam
$174.69 /

+1.64 (+0.95%)

Hot Stocks
Applied Genetic reports 12-month data from ongoing Phase 1/2 trial of ACHM A3 » 07:15
06/24/21
06/24
07:15
06/24/21
07:15
AGTC

Applied Genetic

$4.17 /

+0.02 (+0.48%)

Applied Genetic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

06/14/21 BTIG
Applied Genetic initiated with a Buy at BTIG
04/19/21 Roth Capital
Roth Capital 'bullish' on Applied Genetic's technology, pipeline outlook
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

  • 28
    Jan
AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

Hot Stocks
Applied Genetic reports 12-month data from ongoing Phase 1/2 trial of ACHM B3 » 07:15
06/24/21
06/24
07:15
06/24/21
07:15
AGTC

Applied Genetic

$4.17 /

+0.02 (+0.48%)

Applied Genetic reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

06/14/21 BTIG
Applied Genetic initiated with a Buy at BTIG
04/19/21 Roth Capital
Roth Capital 'bullish' on Applied Genetic's technology, pipeline outlook
04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

  • 28
    Jan
AGTC Applied Genetic
$4.17 /

+0.02 (+0.48%)

Hot Stocks
Darden reports Q4 blended same-restaurant sales up 90.4% y/y » 07:15
06/24/21
06/24
07:15
06/24/21
07:15
DRI

Darden

$135.42 /

-0.17 (-0.13%)

Q4 same-restaurant sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$135.42 /

-0.17 (-0.13%)

DRI Darden
$135.42 /

-0.17 (-0.13%)

06/22/21 Baird
Darden risk/reward remains attractive, says Baird
06/22/21 RBC Capital
Darden price target raised to $162 from $158 at RBC Capital
06/09/21 Truist
Darden price target raised to $170 from $158 at Truist
06/01/21 Barclays
Darden price target lowered to $157 from $164 at Barclays
DRI Darden
$135.42 /

-0.17 (-0.13%)

DRI Darden
$135.42 /

-0.17 (-0.13%)

DRI Darden
$135.42 /

-0.17 (-0.13%)

Hot Stocks
XPO Logistics named official transport partner of Tour de France » 07:14
06/24/21
06/24
07:14
06/24/21
07:14
XPO

XPO Logistics

$148.24 /

+0.46 (+0.31%)

XPO Logistics will take…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$148.24 /

+0.46 (+0.31%)

XPO XPO Logistics
$148.24 /

+0.46 (+0.31%)

06/18/21 Wells Fargo
XPO Logistics price target raised to $183 from $158 at Wells Fargo
06/18/21 Barclays
XPO Logistics price target raised to $180 from $160 at Barclays
06/17/21 Truist
XPO Logistics price target raised to $176 from $160 at Truist
06/10/21 KeyBanc
XPO Logistics price target raised to $175 from $170 at KeyBanc
XPO XPO Logistics
$148.24 /

+0.46 (+0.31%)

XPO XPO Logistics
$148.24 /

+0.46 (+0.31%)

XPO XPO Logistics
$148.24 /

+0.46 (+0.31%)

Recommendations
UBS analyst says GE 'most vaccine-levered stock' in coverage » 07:14
06/24/21
06/24
07:14
06/24/21
07:14
GE

General Electric

$12.95 /

-0.065 (-0.50%)

UBS analyst Markus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$12.95 /

-0.065 (-0.50%)

GE General Electric
$12.95 /

-0.065 (-0.50%)

05/19/21 Barclays
Barclays ups target on top pick GE to $16 on improving aviation data
05/14/21 Citi
General Electric reinstated with a Buy at Citi
04/29/21 Stephens
AerCap named a Best Idea at Stephens
04/28/21 Deutsche Bank
General Electric price target raised to $15 from $14 at Deutsche Bank
GE General Electric
$12.95 /

-0.065 (-0.50%)

GE General Electric
$12.95 /

-0.065 (-0.50%)

GE General Electric
$12.95 /

-0.065 (-0.50%)

GE General Electric
$12.95 /

-0.065 (-0.50%)

Initiation
Inovio initiated with a Hold at Jefferies » 07:13
06/24/21
06/24
07:13
06/24/21
07:13
INO

Inovio

$8.68 /

-0.05 (-0.57%)

Jefferies analyst Kelechi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INO Inovio
$8.68 /

-0.05 (-0.57%)

INO Inovio
$8.68 /

-0.05 (-0.57%)

05/10/21 Piper Sandler
Inovio price target lowered to $6 from $7 at Piper Sandler
05/10/21 Piper Sandler
Inovio Phase 2 data for INO-4800 'lackluster,' says Piper Sandler
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/23/21 Oppenheimer
Oppenheimer still bullish on Inovio after U.S. discontinues trial funding
INO Inovio
$8.68 /

-0.05 (-0.57%)

  • 21
    Jan
INO Inovio
$8.68 /

-0.05 (-0.57%)

INO Inovio
$8.68 /

-0.05 (-0.57%)

Recommendations
Aspen Group a good entry point following retreat from highs, says Canaccord » 07:12
06/24/21
06/24
07:12
06/24/21
07:12
ASPU

Aspen Group

$7.00 /

+1.04 (+17.45%)

Canaccord analyst Austin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASPU Aspen Group
$7.00 /

+1.04 (+17.45%)

ASPU Aspen Group
$7.00 /

+1.04 (+17.45%)

05/18/21 Roth Capital
Aspen Group risk/reward 'highly favorable,' says Roth Capital
03/01/21 Craig-Hallum
Aspen pullback on CFO departure presents buying opportunity, says Craig-Hallum
01/06/21 Roth Capital
Arizona nursing school results positive for Aspen, says Roth Capital
09/22/20 B. Riley FBR
Aspen Group price target raised to $15 from $14 at B. Riley FBR
ASPU Aspen Group
$7.00 /

+1.04 (+17.45%)

ASPU Aspen Group
$7.00 /

+1.04 (+17.45%)

ASPU Aspen Group
$7.00 /

+1.04 (+17.45%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.